(Q38444981)

3 September 2017

Recombinant proteins in therapeutics: haemophilia treatment as an example (English)

1 reference

3 September 2017

0 references

Antonio Liras

1

1 reference

PMC publication ID

2383885

3 September 2017

language of work or name

English

0 references

publication date

28 April 2008

1 reference

International Archive of Medicine

3 September 2017

1 reference

3 September 2017

1

1 reference

3 September 2017

1

1 reference

3 September 2017

4

1 reference

Consideration in hemophilia therapy selection

3 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Probable person-to-person transmission of avian influenza A (H5N1)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Safety of growth hormone replacement therapy in adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Treating haemophilia A with recombinant blood factors: a comparison

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

The promise of third-generation recombinant therapy and gene therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2383885

Phase I comparability of recombinant human albumin and human serum albumin

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18471268

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1755-7682-1-4

1 reference

3 September 2017

1 reference

PMC publication ID

2383885

3 September 2017

PubMed publication ID

18471268

1 reference

PMC publication ID

2383885